Please type a search term (at least two characters)
News
World's first primary standard developed for molecular radiotherapy
Researchers from EMRP project develop the world's first primary standard for molecular radiotherapy (MRT) to treat cancer
The new standard will help improve the consistency of MRT treatments, in which radioactive molecules, or radiopharmaceuticals, are injected directly into a patient's body to target and kill cancerous cells. Such standardisation is vital to encourage more widespread use of MRT and develop new and improved radiopharmaceuticals.
Like any form of radiotherapy, the success of MRT relies on the delivery of an extremely precise dose of radiation. The goal is to maximise the dose delivered to the tumour, while minimising damage to surrounding healthy tissue. However, in contrast to other forms of radiotherapy, dosimetry for MRT is not well established. Researchers from EMRP project Metrology for molecular radiotherapy (HLT11 MetroMRT) developed the new standard. A gas-filled ionisation chamber, containing two parallel electrodes an adjustable distance apart, enables the user to measure the absorbed radiation dose from a radioactive solution.
Research on thin films to be published in the peer-reviewed journal Physical Review Letters more
Aberdeen, Scotland, 22 – 24 October 2018 (additional workshop and training 25 & 26 October) more
University of Salamanca, Spain, 27 – 31 May 2019 more
European electrical power industry already benefitting from recently completed project more
EMPIR project research sparks extensive media coverage more